- Home
- SVV vs RCKT Comparison
SVV vs RCKT Comparison
Compare SVV & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVV
- RCKT
- Stock Information
- Founded
- SVV 1954
- RCKT 1999
- Country
- SVV United States
- RCKT United States
- Employees
- SVV N/A
- RCKT N/A
- Industry
- SVV Other Specialty Stores
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- SVV Consumer Discretionary
- RCKT Health Care
- Exchange
- SVV Nasdaq
- RCKT Nasdaq
- Market Cap
- SVV 1.2B
- RCKT 1.1B
- IPO Year
- SVV 2023
- RCKT N/A
- Fundamental
- Price
- SVV $7.00
- RCKT $7.59
- Analyst Decision
- SVV Buy
- RCKT Strong Buy
- Analyst Count
- SVV 6
- RCKT 10
- Target Price
- SVV $11.67
- RCKT $44.10
- AVG Volume (30 Days)
- SVV 828.2K
- RCKT 1.6M
- Earning Date
- SVV 05-08-2025
- RCKT 05-05-2025
- Dividend Yield
- SVV N/A
- RCKT N/A
- EPS Growth
- SVV N/A
- RCKT N/A
- EPS
- SVV 0.17
- RCKT N/A
- Revenue
- SVV $1,537,617,000.00
- RCKT N/A
- Revenue This Year
- SVV $7.05
- RCKT N/A
- Revenue Next Year
- SVV $7.53
- RCKT N/A
- P/E Ratio
- SVV $41.24
- RCKT N/A
- Revenue Growth
- SVV 2.49
- RCKT N/A
- 52 Week Low
- SVV $6.48
- RCKT $7.48
- 52 Week High
- SVV $19.72
- RCKT $26.99
- Technical
- Relative Strength Index (RSI)
- SVV 37.39
- RCKT 34.04
- Support Level
- SVV $6.85
- RCKT $8.22
- Resistance Level
- SVV $7.23
- RCKT $8.80
- Average True Range (ATR)
- SVV 0.34
- RCKT 0.48
- MACD
- SVV 0.15
- RCKT -0.02
- Stochastic Oscillator
- SVV 63.41
- RCKT 7.72
About SVV Savers Value Village Inc.
Savers Value Village Inc is a for-profit thrift operator in the United States and Canada. It purchases second hand textiles (i.e., clothing, bedding, and bath items), shoes, accessories, housewares, books, and other goods from its non-profit partners (NPPs), either directly from them or via on-site donations (OSDs) at Community Donation Centers at its stores. The company then processes, selects, prices, merchandise, and sells these items in its stores.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.